Agilent “Dialogues in CDx” Podcast Series

In Episode 7 of Agilent’s Dialogues in CDx, we turn our focus to recent advances in head and neck cancers, a field marked by rapid evolution in diagnostics and clinical decision‑making. To unpack what’s changing and why it matters for patient care, we welcome two specialists at the forefront of this space, offering complementary insights from pathology and oncology. Professor Cécile Badoual is a p...

In episode number 6 of Agilent’s “ Dialogues in CDx ” podcast, we explore how to bridge the gap between clinical data and the realities of daily laboratory practice. To unpack this topic, we are joined by two distinguished experts who bring complementary perspectives from pathology and oncology. Dr. Birgit Guldhammer Skov, consultant pathologist at the Department of Pathology, Sjaelland University...

In the fifth episode of Agilent’s “ Dialogues in CDx ” podcast, we discuss how to ensure proper training for PD-L1 interpretation. Two leaders who are shaping this space discuss why training is important, the best practices, and how it impacts patient care.  The first guest in this episode is Dr. Bharat Jasani , Emeritus Professor in Cancer Pathology in the School of Medicine at Cardiff University...

In the fourth episode of the “Dialogues in CDx” podcast series, we explore the issue of sample limitations and how pathologists can address them when performing PD-L1 testing. Two leaders in gastrointestinal pathology join the host Scott W. Boyer in an engaging discussion of the main challenges and solution strategies.   Dr. Mar Iglesias Coma is Head of the Pathology Department at Hospital del Mar...

In this third episode of the "Dialogues in CDx" podcast series, you’ll listen to the distinguished guests Dr. Phillippe Taniere and Dr. Shobhit Baijal once more. The previous episode dissected the PD-L1 testing journey from biopsy to report. This episode will focus on the topic of PD-L1 reporting: What information should the pathologist provide for the oncologist? What information helps the oncolo...

In this inaugural episode of the "Dialogues in CDx" podcast series, you’ll hear about the intricate relationship between diagnostic cutoffs and clinical data. In the PD-L1 space, there are multiple scoring algorithms, cutoffs, assays, and staining platforms for various indications, leading to frustration among pathologists. This episode centers on the question "Why is the PD-L1 doma...

The second episode of the "Dialogues in CDx" podcast series takes a closer look at the PD-L1 testing journey. Using England as example, you’ll learn about the process from start to finish, and topics, such as the importance of turnaround times, reflex testing, optimal oncologist-pathologist collaboration, and more, are discussed.   Joining this discussion are two esteemed guests, providing perspec...

In this new podcast series, Agilent brings together leading pathologists, oncologists, and CDx specialists to explore key challenges and solutions in the field of companion diagnostics. Through peer-to-peer discussions, these experts share fresh insights, real-world approaches, and the latest developments shaping the field. Stay tuned for episode 1 that will be launched on May 20. This podcast ser...